Free Trial
LON:RIII

Rights & Issues Investment Trust (RIII) Share Price, News & Analysis

Rights & Issues Investment Trust logo
GBX 2,206 +17.67 (+0.81%)
As of 11:52 AM Eastern

About Rights & Issues Investment Trust Stock (LON:RIII)

Key Stats

Today's Range
2,150
2,206
50-Day Range
1,865
2,215
52-Week Range
1,670
2,500
Volume
1,515 shs
Average Volume
4,564 shs
Market Capitalization
£106.64 million
P/E Ratio
7.01
Dividend Yield
1.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rights & Issues Investment Trust and its competitors with MarketBeat's FREE daily newsletter.

RIII Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

RIII Stock Analysis - Frequently Asked Questions

Rights & Issues Investment Trust's stock was trading at GBX 2,378.49 at the beginning of the year. Since then, RIII stock has decreased by 7.3% and is now trading at GBX 2,206.

Rights & Issues Investment Trust (LON:RIII) posted its earnings results on Friday, February, 21st. The company reported $42.10 earnings per share (EPS) for the quarter. Rights & Issues Investment Trust had a net margin of 93.27% and a trailing twelve-month return on equity of 12.60%.

Shares of RIII stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rights & Issues Investment Trust investors own include Milestone Pharmaceuticals (MIST), Ovintiv (OVV), SIG (SHI), Allena Pharmaceuticals (ALNA), Alpine Immune Sciences (ALPN), Affiliated Managers Group (AMG) and Aravive (ARAV).

Company Calendar

Last Earnings
2/21/2025
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:RIII
CIK
N/A
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 314.53
Trailing P/E Ratio
7.01
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£15.28 million
Net Margins
93.27%
Pretax Margin
N/A
Return on Equity
12.60%
Return on Assets
1.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.38
Quick Ratio
60.63

Sales & Book Value

Annual Sales
£16.38 million
Price / Sales
6.51
Cash Flow
GBX 182.20 per share
Price / Cash Flow
12.11
Book Value
GBX 2,584.15 per share
Price / Book
0.85

Miscellaneous

Outstanding Shares
4,834,231
Free Float
N/A
Market Cap
£106.64 million
Optionable
Not Optionable
Beta
0.74
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (LON:RIII) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners